Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.66 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.66 |
| ▸ | SSTR4 | P31391 | 7/20 | 0.38 |
| ▸ | SSTR2 | P30874 | 7/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 6/20 | 0.38 |
| ▸ | SSTR1 | P30872 | 2/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.38 |
| ▸ | KLK7 | P49862 | 2/20 | 0.38 |
| ▸ | LDHB | P07195 | 3/20 | 0.36 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14241072 | 1.00 | KDM1A (0.66) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL14241375 | 0.95 | KDM1A (0.62) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL22678369 | 0.95 | KDM1A (0.68) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL14226791 | 0.95 | KDM1A (0.74) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL14240945 | 0.95 | KDM1A (0.74) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL14240739 | 0.94 | KDM1A (0.59) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL22678374 | 0.90 | KDM1A (0.61) | KDM1ARCOR1KLK7F11 | |
| SCHEMBL22678352 | 0.90 | KDM1A (0.61) | KDM1ARCOR1KLK7F11 | |
| SCHEMBL14240943 | 0.90 | KDM1A (0.69) | KDM1ARCOR1SSTR4SSTR2SSTR5 | |
| SCHEMBL14241078 | 0.90 | KDM1A (0.69) | KDM1ARCOR1SSTR4SSTR2SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012168820-A1 | POLYMYXIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 2012-12-13 | — | — | WO | disclosed |
| US-20120316105-A1 | Polymyxin Derivates Useful As Antibacterial Agents | PFIZER INC. | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316105-A1 | Polymyxin Derivates Useful As Antibacterial Agents | NPEPPS, MDN1, PNKP | KDM1A 3854/4885RCOR1 4836/4885SSTR4 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.